Cargando…
Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
OBJECTIVE: Schizophrenia is a disabling disorder of unknown aetiology, lacking definite diagnostic method and cure. A reliable biological marker of schizophrenia is highly demanded, for which traceable immune mediators in blood could be promising candidates. We aimed to gather the best findings of n...
Autores principales: | Trovão, Nuno, Prata, Joana, VonDoellinger, Orlando, Santos, Susana, Barbosa, Mário, Coelho, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444098/ https://www.ncbi.nlm.nih.gov/pubmed/30836740 http://dx.doi.org/10.30773/pi.2018.12.19.1 |
Ejemplares similares
-
Combining inflammatory miRNA molecules as diagnostic biomarkers for depression: a clinical study
por: Brás, João Paulo, et al.
Publicado: (2023) -
Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review
por: Ochoa, Susana, et al.
Publicado: (2012) -
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations
por: Prata, Joana, et al.
Publicado: (2017) -
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis
por: Davidson, Michael, et al.
Publicado: (2005) -
Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk, Małgorzata, et al.
Publicado: (2019)